Imatinib Completed Phase 2 Trials for Acute Lymphoblastic Leukaemias (ALL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00130195Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)
NCT00376467STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia
NCT00973752Treatment of Older Adults With Acute Lymphoblastic Leukemia